C. difficile

Hospitalized patients with Clostridium difficile (C. difficile) infection are at an increased risk of colonization if they are considered frail.

A majority of the children with C. difficile were prescribed at least 1 antibiotic in the 12 weeks leading up to their diagnosis.

A recently-published study in JAMA suggests that Clostridium difficile may be more effectively treated with vancomycin than its more commonly used counterpart metronidazole.

Using bezlotoxumab lowers the rate of recurrent Clostridium difficile infection more than a placebo alone, according to results of 2 phase 3 trials published this week in the New England Journal of Medicine.

Roche's new tests to detect Clostridium difficile and genital herpes infection have been cleared by the FDA.

Clostridium difficile-associated diarrhea (CDAD) is an increasingly common cause of inpatient mortality, and recurrent CDAD remains clinically challenging.

The US Centers for Disease Control and Prevention today reported that nearly half a million Clostridium difficile infections occurred in a single year, highlighting a critical need for improved antibiotic use.